Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis.
about
Inhaled corticosteroids for stable chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseMinimal clinically important difference, clinical perspective: an opinion.Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease.Influencing the decline of lung function in COPD: use of pharmacotherapy.Inhaled corticosteroids and mortality in chronic obstructive pulmonary diseaseEffect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease.Drugs in clinical development for chronic obstructive pulmonary disease.Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease.Autoreactive T Cells in Human Smokers is Predictive of Clinical Outcome.Systemic inflammation and decline in lung function in a general population: a prospective studyMinimal clinically important differences in COPD lung function.Role of tiotropium in the treatment of COPD.Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studiesInhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.Defining disease modification in chronic obstructive pulmonary disease.Is there a role for antiinflammatory treatment in COPD?Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction.Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy.Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.How have we been managing chronic obstructive pulmonary disease in Australia?Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid-independent mechanism.Modification of the rat airway explant transcriptome by cigarette smoke.Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
P2860
Q24202092-96BB9F0D-2C72-4C49-9625-D3E3927E6115Q24245481-DBBE3500-D39C-4A59-93C4-12F5FDE3311FQ30542113-348BFFF5-68D1-45B4-ACA1-6EE50EC72F9AQ33932911-BF45156C-D006-4341-BDD9-01FD99EB2C74Q33966001-FADDBE6C-5032-41A8-BC0C-373FDF2056DAQ35537366-A599067C-CF06-4DAE-B8E6-4D64C05B5C2BQ35537629-82296206-106D-4F0A-8CE0-1FEE1B9D8016Q35876360-80BCB619-076D-4A70-9592-846A1176A6A5Q36064621-C1F23258-A4B4-4CF6-BB93-D9A04E4FDDABQ36148623-CCE9C153-3D5E-41CF-B8AD-D2CA4B4A3B28Q36190792-3D443896-EBD8-4703-A141-C9103CB7D1B5Q36225737-7B1E5237-C6C7-48FD-B08C-AFA028792A6CQ36669438-5DBA5143-2DFA-4A29-B332-D9B3EDF984CEQ37017516-6DCB582F-8B40-4208-B8E6-B72CA8DC86D6Q37199668-02837E2C-412E-44DC-8F30-D58AB4DC2F99Q37532050-656C4C2F-0C58-47A5-AB15-A6BA529D74A0Q37610458-8723F99E-5510-4A5C-BD4F-1BCF49B1E7ADQ37622935-256D4C94-F74C-4E6C-8FDC-F702B4FB97A0Q37895710-FD4BA454-C5CD-4042-9D53-F1EE81D6705AQ38021518-6BDE5B48-E1D7-44A4-BFA8-6BA54C3D77B6Q38495012-3A3682D3-D13E-444C-B3C3-715B317BA3D5Q39461476-1BA993D9-D4B0-4975-9CFC-A1C13048148CQ45917632-12ACDA9D-1470-494A-846C-738CBC1A3DA8Q46448011-B333C016-D709-4472-A9DD-B5EF12A7506EQ46568144-3F0203A4-9995-45A0-9073-8C20AFB40510Q46939614-B8D82C5D-EEBF-4AEF-B1BF-2ACAA154949FQ47930405-248DF6B5-EF1A-49A8-B1EE-F5316758B80AQ54456425-90D15BC6-9018-4995-90CC-93F251F57D7CQ58700920-0ECC2520-6E44-4791-92FC-8C9069C60722
P2860
Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@ast
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@en
type
label
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@ast
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@en
prefLabel
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@ast
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@en
P2093
P1476
Long-term effects of inhaled c ...... nary disease. A meta-analysis.
@en
P2093
Charlie Strange
John E Heffner
Kristin B Highland
P304
P356
10.7326/0003-4819-138-12-200306170-00008
P407
P577
2003-06-01T00:00:00Z